2.1101
Mainz Biomed N V Aktie (MYNZ) Neueste Nachrichten
Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies - GlobeNewswire
Mainz Biomed Expands Early Cancer Detection Program to 19 German Health Insurers Through CARE Partnership - Stock Titan
When the Price of (MYNZ) Talks, People Listen - news.stocktradersdaily.com
What drives Mainz Biomed N.V. stock priceExceptional profit velocity - Autocar Professional
Is Mainz Biomed N.V. a good long term investmentDynamic portfolio growth - jammulinksnews.com
What analysts say about Mainz Biomed N.V. stockTremendous financial leverage - Autocar Professional
Mainz Biomed N.V. Stock Analysis and ForecastBreakthrough profits - Autocar Professional
Why Mainz Biomed N.V. stock attracts strong analyst attentionFree Long-Term Wealth Growth Plan - beatles.ru
Mainz Biomed (NASDAQ:MYNZ) Trading Up 7% – Here’s Why - Defense World
Mainz Biomed Half Year 2025 Update: Accelerating FDA - GlobeNewswire
What makes Mainz Biomed N.V. stock price move sharplyFree Stock Market Expert Consultation - Newser
ARBI(arbipad) News and UpdatesProtected Capital Trading Plan - Newser
How Mainz Biomed N.V. stock performs during market volatilityFree Step-by-Step Investment Guide - Newser
Mainz Biomed reviews accomplishments for first half of 2025 - TipRanks
Mainz Biomed N.V. Announces Key Achievements and Corporate Update for First Half of 2025 - Nasdaq
Mainz Biomed's Dual Breakthrough: FDA Trial Progress and Revolutionary 95% Accurate Pancreatic Cancer Detection - Stock Titan
Mainz Biomed (MYNZ) Secures State Funding for Pancreatic Cancer Project | MYNZ Stock News - GuruFocus
Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test - FinancialContent
Mainz Biomed (MYNZ) to Release Quarterly Earnings on Tuesday - Defense World
Where are the Opportunities in (MYNZ) - news.stocktradersdaily.com
Mainz Biomed (NASDAQ:MYNZ) Trading Down 1.9% – Here’s What Happened - Defense World
(MYNZ) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Mainz Biomed (MYNZ) Advances PancAlert Project for Pancreatic Ca - GuruFocus
Mainz Biomed Initiates Feasibility Study Of PancAlert Blood Test For Pancreatic Cancer Detection - Nasdaq
Mainz Biomed Initiates Feasibility Study Of Biomarker Panel In Pancreatic Cancer Project - MarketScreener
Mainz Biomed (MYNZ) Advances PancAlert Project for Pancreatic Cancer Detection | MYNZ Stock News - GuruFocus
Mainz Biomed Initiates Feasibility Phase for Non-Invasive Pancreatic Cancer Screening Test in PancAlert Project - Nasdaq
Mainz initiates feasibility study of biomarker panel in PancAlert project - TipRanks
Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project - The Manila Times
Mainz Biomed N.V. Shareholders Approve Key Proposals at Annual Meeting - TipRanks
Maxim Group to Act as Sole Placement Agent for MYNZ Offering | M - GuruFocus
Mainz Biomed N.V. Secures $4 Million Through Securities Offering - TipRanks
Mainz Biomed (NASDAQ:MYNZ) Trading Up 5.4% – What’s Next? - Defense World
Mainz Biomed (MYNZ) Prices $4M Follow-On Offering - GuruFocus
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):